Table 2.

Average screening rate at baseline by cancer focus.

Cancer focus	Performance measure	Average screening rate (range)
Breast (n = 13 projects)	Percentage of women 50–74 years of age who had a mammogram to screen for breast cancer (CMS 125)	44.2% (20.5% - 64.3%)
Cervical (n = 10 projects)	Percentage of patients 21–64 years of age who had the appropriate screening for cervical cancer. (CMS 124)	57.9% (44.5% - 73.1%)
Colorectal (n = 14 projects)	Percentage of patients 50–75 years of age who had the appropriate screening for colorectal cancer. (CMS 130)	36.6% (15.0% - 58.9%)

Note: CMS 125: Percentage of women 50–74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the Measurement Period.

CMS 124: Percentage of patients 21–64 years of age who had the appropriate screening for cervical cancer using the following criteria: cervical cytology performed in the last three years for patients who are at least 21 years old at time of test; cervical cytology/human papillomavirus (HPV) co-testing performed in the last five years for patients who are at least 30 years old at the time of test.

CMS 130: Percentage of patients 5–75 years of age who had the appropriate screening for colorectal cancer, including any of the following: fecal occult blood test (gFOBT or FIT) in the last 12 months; colonoscopy in the last 10 years; FIT-DNA during the last three years; CT colonography in the last five years; and flexible sigmoidoscopy in the last five years.